Glycemic Control

Empagliflozin Reduces Risk for Nephropathy Regardless of Blood Pressure, LDL Cholesterol, HbA1c

Empagliflozin Reduces Risk for Nephropathy Regardless of Blood Pressure, LDL Cholesterol, HbA1c

By

Investigators examined renal outcomes when controlling cardiovascular risk factors, such as blood pressure, LDL-C, and HbA1c.

Implantable Continuous Glucose Monitoring Device Safe, Effective for Adolescents

Implantable Continuous Glucose Monitoring Device Safe, Effective for Adolescents

By

The safety assessment included incidence of insertion or procedure-related removal and device-related serious adverse events through 180 after insertion.

MEDI0382 Safe, Effective for Normalizing Glucose, Weight Loss in Type 2 Diabetes

MEDI0382 Safe, Effective for Normalizing Glucose, Weight Loss in Type 2 Diabetes

By

MEDI0382 reduced body weight and normalized fasting and postprandial blood glucose levels in patients with type 2 diabetes.

ITCA 650 Shows Efficacy in Reducing Weight, HbA1c in Type 2 Diabetes

ITCA 650 Shows Efficacy in Reducing Weight, HbA1c in Type 2 Diabetes

The ITCA 650, a small titanium osmotic mini-pump, provides a subcutaneous infusion of exenatide over 3 or 6 months.

Improving Insulin Access: ADA Public Policy Recommendations

Improving Insulin Access: ADA Public Policy Recommendations

By

The American Diabetes Association (ADA) has released a public policy statement that outlines long- and short-term recommendations for improving insulin affordability.

ACP supports higher HbA1c targets for pharmacotherapy in adults with T2D

ACP supports higher HbA1c targets for pharmacotherapy in adults with T2D

By

ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c level between 7% and 8% in most people with type 2 diabetes.

New type 2 diabetes guideline recommends more moderate HbA1c target

New type 2 diabetes guideline recommends more moderate HbA1c target

By

The American College of Physicians has developed recommendation statements to guide clinicians in selecting targets for pharmacologic treatment of type 2 diabetes.

FDA approves weekly diabetes drug that may also be beneficial for weight loss

FDA approves weekly diabetes drug that may also be beneficial for weight loss

By

The FDA has approved semaglutide injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Commercial weight loss program may help prevent diabetes in obese patients

Commercial weight loss program may help prevent diabetes in obese patients

Primary care referral to Weight Watchers meetings is associated with weight loss, HbA1c reduction.

FDA approves glucose monitoring system to eliminate fingerstick testing

FDA approves glucose monitoring system to eliminate fingerstick testing

The system uses a small sensor implanted below the skin and a mobile reader to continuously monitor blood glucose.

Lifestyle intervention provides minimal benefit in improving glycemic control in type 2 diabetes

Lifestyle intervention provides minimal benefit in improving glycemic control in type 2 diabetes

By

Lifestyle interventions maintain glycemic control in patients with type 2 diabetes.

CPAP leads to improved glycemic control in patients with type 2 diabetes

CPAP leads to improved glycemic control in patients with type 2 diabetes

The CPAP group had a larger decrease in HbA1c levels after 6 months.

Potato consumption pre-pregnancy linked to diabetes

Potato consumption pre-pregnancy linked to diabetes

By

Eating more potatoes before pregnancy may be associated with greater risk of gestational diabetes mellitus,

Getting hemoglobin A1c under control after a relapse

Getting hemoglobin A1c under control after a relapse

By

A patient with diabetes questions the necessity of starting a statin.

Strict glycemic control may decrease cardiovascular events in diabetes patients

Strict glycemic control may decrease cardiovascular events in diabetes patients

The glycated hemoglobin in the intensive control group was 6.9%, on average. For those on standard care, the glycated hemoglobin average was 8.4%.

Patients lack proper hypoglycemia management, prevention knowledge

Patients lack proper hypoglycemia management, prevention knowledge

A majority of patients with diabetes are worried about experiencing hypoglycemia, with many being uncertain about how to manage the condition.

Dizziness, decreased mobility in an elderly diabetes patient

Dizziness, decreased mobility in an elderly diabetes patient

Lack of confidence when mobilizing and hypoglycemia in an elderly lady with type 2 diabetes.

Bariatric surgery improves long-term glycemic control

Bariatric surgery improves long-term glycemic control

Better glycemic control, lower medication use among obese patients with diabetes who undergo bariatric surgery.

FDA approves 3 new diabetes treatments

FDA approves 3 new diabetes treatments

The FDA has approved Nesina, Oseni, and Kazano as adjuncts to diet and exercise for treating adults with type 2 diabetes.

Legume-rich diet improves glycemic control

Legume-rich diet improves glycemic control

Encouraging patients with type 2 diabetes to incorporate legumes into their diet may help improve glycemic control, lower coronary heart disease risk.

Interventions for prediabetes

Interventions for prediabetes

Two clinicians disagree on a diagnosis after reviewing two-hour oral glucose tolerance test results. Who is correct?

How much insulin does it take to lower blood sugar?

How much insulin does it take to lower blood sugar?

A patient with newly diagnosed diabetes has a hemoglobin (Hb) A1c of 12.2% and glucose 350 mg/dL, despite increasing insulin (glargine [Lantus]) to 25 units. What else can be done to lower blood sugar?

FDA approves Accu-Chek Combo insulin pump

FDA approves Accu-Chek Combo insulin pump

The FDA has approved a new insulin pump system -- Roche's Accu-Chek Combo -- that combines a blood glucose meter and insulin pump, which exchange information using Bluetooth technology.

ADA: Glucose control in prediabetes cuts diabetes risk

ADA: Glucose control in prediabetes cuts diabetes risk

Patients with prediabetes who achieve normal glucose regulation, even just one time, have a lower risk for progressing to diabetes.

Hyperglycemia predicts death in pneumonia

Hyperglycemia predicts death in pneumonia

Risk of death at 90 days up for pneumonia patients without preexisting diabetes who present with hyperglycemia.

Combo treatment more effective for glycemic control in adolescents

Combo treatment more effective for glycemic control in adolescents

Rosiglitazone plus metformin beat metformin alone or lifestyle interventions in adolescents with type 2 diabetes.

Twice-daily tablet to control blood sugar

Twice-daily tablet to control blood sugar

Jentadueto is an oral formulation of linagliptin and metformin indicated as an adjunct therapy to diet and exercise for treating type 2 diabetes.

Tight glycemic control not beneficial for premature infants

By

The benefits of tight glycemic control may not outweigh the risks among premature infants with hyperglycemia, results of a randomized clinical trial suggest.

Less than half of new diabetes patients achieve HbA1c goals

Less than half of new diabetes patients achieve HbA1c goals

Initiating insulin therapy at lower levels of HbA1c may help patients attain glycemic control.

Novel diabetes drug improves glycemic control

Novel diabetes drug improves glycemic control

TAK-875 increased insulin secretion without raising hypoglycemia risk in patients with type 2 diabetes who did not respond to diet modification or treatment with metformin.

Sign Up for Free e-newsletters